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Summary
Objective: To better assess the diagnosis of an infection in patients presenting at an emergency
department with peripheral blood leukocytosis (>10  109 cells/l) on laboratory testing.
Methods: We prospectively evaluated serum procalcitonin concentration (PCT), C-reactive
protein (CRP), and erythrocyte sedimentation rate (ESR). Patients were divided into two groups
according to their final diagnosis: patients with infection and those without infection. PCT, CRP,
and ESR were compared between these groups. Sensitivity, specificity, positive predictive values,
negative predictive values, receiver operating characteristic curves, and areas under the curves
were calculated for each biological measurement.
Results: Out of 173 patients, 99 (57%) had a final diagnosis of systemic infection. If a cutoff point of
0.5 ng/ml is considered,procalcitonin concentrationhada sensitivity of 0.57, a specificity of 0.85, a
negative predictive value of 0.59, and a positive predictive value of 0.84 for the diagnosis of a
systemic infection. Adding CRP or ESR to PCT gave no more information (p = 0.84).
Conclusions: Only about half of the patients attending the emergency department with leuko-
cytosis were suffering from an infection. Determination of the procalcitonin level may be useful for
these patients, particularly in the case of a value higher than 0.5 ng/ml.
# 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Early diagnosis of an infection and prompt administration of an
antibiotic can dramatically reduce morbidity and mortality.1,2* Corresponding author. Tel.: +41 32 9672111; fax: +41 32 9672729.
E-mail address: daniel.genne@ne.ch (D. Genne´).
1201-9712/$32.00 # 2007 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2007.09.007Most patients who present at an emergency room with a
suspicion of an infection have fever and/or leukocytosis. For
these patients, many markers, like the erythrocyte sedimen-
tation rate (ESR) and the C-reactive protein (CRP) can be of
some help, but they lack sensitivity and specificity.3,4 Micro-
biological test results are rarely rapidly available, and the
sensitivity of some of these tests, such as blood culture, is
pretty low, close to25%.5A rapidand reliable test to ruleout anPublished by Elsevier Ltd. All rights reserved.
320 P. Indino et al.infectionwould thus help indecision-making andcouldhavean
impact both on the length of hospital stay and on costs. Levels
of procalcitonin, a 116-amino acid polypeptide, have been
found to be low in the serumof healthy humans but elevated in
persons suffering fromsevere infections, particularly sepsis.6,7
This study was designed to determine the usefulness of
measuring procalcitonin levels in the diagnosis of infections in
adult patients with leukocytosis who attended the emergency
room of the hospital at La Chaux-de-Fonds, Switzerland. We
investigated a test strategy in which procalcitonin is used to
strengthen the diagnosis of infection in cases of suspected
infection based on peripheral leukocytosis. Procalcitonin was
compared with ESR and CRP to determine the sensitivity and
specificity of these markers. The diagnostic performance of
these tests when combined was also evaluated.
Patients and methods
Study design
This was a prospective study approved by the local ethics
committee. It was performed over a period of one year,
between 2002 and 2003, in the department of medicine
and the intensive care unit of a 250-bed community hospital
in La Chaux-de-Fonds, Switzerland. We analyzed the clinical
usefulness of measuring inflammatory markers in diagnosing
infection in patients with leukocytosis who attended the
emergency department.
Selection of participants
All adult patients with peripheral blood leukocytosis defined
as a white blood cell (WBC) count of >10  109/l, who
attended the emergency room and needed to be hospita-
lized, were eligible. Those selected to participate in the
study gave written consent. Exclusion criteria included all
causes that could increase the procalcitonin level, such as
thyroid carcinoma, small cell pulmonary carcinoma, multiple
trauma, major abdominal surgery in the last 7 days,8 pul-
monary inhalation of burning steam, and heat stroke.9
The patients were divided into two groups according to
the final diagnosis at the end of their hospital stay: group I
included all patients with an infection, and group II, those
without an infection. Patients of group II who developed a
nosocomial infection during their hospitalization, remained
in the same group, as the first diagnosis for which they were
hospitalized was not an infection. To belong to group I,
patients had to present with all the definition criteria of
an infection. The criteria used to diagnose the main infec-
tions were as follows: (1) pneumonia: fever >38 8C or new
dyspnea or new sputum or chest pain or new cough with a new
pulmonary infiltrate on chest X-ray (all patients had leuko-
cytosis as defined above); (2) pyelonephritis: fever >38 8C
with flank pain or dysuria, urgency, frequency of urination
and/or positive blood cultures or urinary culture for a sug-
gestive microorganism, and pyuria; (3) bacteremia: presence
of viable bacteria in the blood, as demonstrated by a positive
blood culture (false-positive blood cultures were excluded);
(4) skin infection: fever >38 8C with an erythematous, swol-
len, tender skin and/or discharge of purulent material; (5)
meningitis: headache, fever>38 8C, lethargy, confusion, andstiff neck with a high WBC count in the cerebrospinal fluid
and/or typical bacteria; (6) arthritis: fever>38 8C with pain,
erythema, tenderness, swelling, and limitation of motion of a
joint with bacteria found in direct joint aspiration (patients
had to be off antibiotics in the previous week); (7) appendi-
citis: fever>38 8C with abdominal pain and tenderness in the
right lower quadrant associated with a histology compatible
with inflammation after surgical removal of the appendix; (8)
cholecystitis and cholangitis: fever >38 8C with abdominal
pain and tenderness in the right upper quadrant associated
with a suggestive ultrasonography result. Fever could be
absent for all infections, but in these cases, all other symp-
toms had to be present.
Methods of measurement
In the case of a WBC count higher than 10  109/l, patients
were enrolled in the study. A second blood sample was then
taken with a maximum delay of 12 hours, and procalcitonin,
CRP, and ESR were measured. We also measured the leuko-
cyte differential count, creatinine, transaminases, and arter-
ial oxygen saturation, and performed urinary sediments and
chest X-rays. Microbiological samples (blood for culture and
serology (Mycoplasma pneumoniae, Legionella pneumophila,
Coxiella burnetti, Chlamydia spp, Borrelia spp) and sputum,
urine, cerebrospinal fluid, and stool for culture) were further
collected according to symptoms, clinical diagnosis, chest X-
ray, and laboratory findings. Blood samples were obtained by
venipuncture and collected in one EDTA tube, one citrate 1/
10 tube, one Li-heparinate tube, and two serum-gel tubes
(Sarstedt, Sevelen, Switzerland). The centrifuged serum was
stored at 20 8C before assay whereas all other parameters
were analyzed immediately. Leukocytes were counted using
a flux cytometer (Cell-Dyn 3200, Abbott, Baar, Switzerland).
CRP concentrations were measured by turbidimetric assay
with the Dimension RXL system (Dade-Behring, Du¨dingen,
Switzerland). ESR was performed by the Westergren method
(Sedplus, Sarstedt, Sevelen, Switzerland). Procalcitonin was
measured by immunoluminometric assay (LUMItest PCT kit,
BRAHMS Diagnostica, Hennigsdorf bei Berlin, Germany).
The measurement of chemiluminescence was performed
with a luminometer (Lumat, LB 9507, Berthold, Wildbad,
Germany). Two specific monoclonal antibodies bonded the
procalcitonin at two different sites (calcitonin and katacalcin
segments). One of these sites was luminescence-labeled.
After 90 minutes of incubation, luminescence was measured.
The inter-assay coefficients of variation were 10%. The mini-
mum detectable procalcitonin concentration was 0.1 mg/l.
The procalcitonin reference cutoff was chosen according to
BRAHMS diagnostic reference tables, i.e.: <0.5 ng/ml for
normal subjects, chronic inflammatory processes and auto-
immune diseases, and viral infections; 0.5—2 ng/ml for mild
to moderate localized bacterial infections, systemic inflam-
matory response syndrome, multiple trauma, and burns; and
>2.0 ng/ml for severe bacterial infections and sepsis with
multiple organ failure.
Data analysis
Demographic and clinical data were prospectively collected.
They included age, gender, date of admission, symptoms and
clinical diagnosis, previous administration of antibiotics and
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Table 1 Baseline characteristics of patients with an infection (group I) and those without an infection (group II)
Group I (N = 99) 95% CI Group II (N = 74) 95% CI p-Value
Mean age (years, min—max) 64.2 60.2—68 68.4 64.6—72.2 0.25
Male (%) 61 (62) 39 (53) 0.3
Mean blood pressure (mmHg) 139/78 133—145/75—81 141/83 134—147/79—87 0.35 systolic
0.03 diastolic
Mean pulse rate (/min) 96 92—101 91 86—96 0.11
Mean respiratory rate (/min) 23 21—25 22 20—24 0.49
Mean arterial oxygen saturation (%) 89.6 87.7—91.5 90.6 86.7—94.5 0.008
Death 4 7 0.2
Table 2 Final diagnosis for patients who were admitted to
an emergency room with leukocytosis and an infection
(group I)
Diagnosis No. of patients (%)
(N = 99)a
Respiratory 43 (43)
Urinary 24 (24)
Osteo-articular 11 (11)
Bacteremia 9 (9)
Gastrointestinal b 4 (4)
Neurological c 1 (1)
Miscellaneous 8 (8)
a Patients could have more than one infection.
b Two cholangitis, two appendicitis.
c Meningitis.systemic steroids within 48 hours, heart rate, blood pressure,
and body temperature when the first blood samples were
taken. To compare the demographic and clinic characteris-
tics among groups I and II, we used the unpairedWilcoxon test
for continuous variables. Independence between qualitative
variables and groups were tested using the Chi-square test
with Yates’ continuity correction.
Multiple logistic regression models were used to predict
infection as a definite diagnosis. The models were system-
atically adjusted for age and gender. Sensitivity (Sens),
specificity (Spec), positive predictive values (PV+), negative
predictive values (PV), receiver operating characteristic
curves (ROC), and areas under the curves (AUC) were calcu-
lated for each biological measurement. To determine these
values, a cutoff point was established for the maximum of
sensitivity and specificity. In addition, the non-parametric
statistical comparison between the AUC values was per-
formed using the method described by Delong et al.10 after
alpha-adjustment by Bonferroni.11 Statistical analyses and
graphical representations were performed on R version 2.2.1
(a language for data analysis and graphics, http://cran.r-
project.org/).
Results
A total of 2259 patients were referred to the emergency room
of our hospital for hospitalization during the study period, of
whom 238 had leukocytosis (11%). Sixty-five (27%) presented
an exclusion criterion or were lost to follow-up and were
excluded from further analysis. The major reasons that
patients were lost to follow-up were lack of data, mainly
due to premature departure from the hospital or death
(without an autopsy), and refusal to participate in the study.
Of the remaining 173 patients, 73 were women (42%) and 100
were men (58%). Ninety-nine (57%) of these 173 patients
received a final diagnosis of a systemic infection (group I).
The other 74 (43%) had a different final diagnosis and were
classified as having no systemic infection (group II); most of
them were suffering from a respiratory (n = 26, 35%), a
cardiovascular (n = 23, 31%), or a neurological (n = 11, 15%)
event. The demographic characteristics of both groups are
shown in Table 1. Apart from arterial oxygen saturation and
diastolic blood pressure, all variables were similar in both
groups. The difference in the arterial oxygen saturation can
be explained by the high number of patients with pneumonia
in group I, and the lower diastolic blood pressure is common
and expected in systemic infections. The death rate was
similar in both groups (four in group I vs. seven in group II,
p = 0.2).Final diagnosis infection types for group I are summarized
in Table 2.
Twenty-five (14%) of the 173 patients (16 in group I and
nine in group II) were taking antibiotics prior to admission to
the hospital. Fever was present in 42 patients with an infec-
tion and in 10 without an infection ( p < 0.0001). As
expected, mean temperature, procalcitonin, CRP value,
and ESR on the first day of hospitalization were all strongly
related to an infection (Table 3). Leukocytosis was also
significantly higher in the group with an infection. When
adjusted for age and gender, the ROC for leukocytosis linked
to an infection showed a weak sensitivity (0.45) and rela-
tively good specificity (0.82) (Figure 1).
Using the procalcitonin values, a sensitivity of 0.40, a
specificity of 0.92, a positive predictive value of 0.87, and a
negative predictive value of 0.54 were measured. However,
due to the non-linear distribution of the values, we used a
cutoff point of 0.5 ng/ml, giving a sensitivity of 0.57, a
specificity of 0.85, a positive predictive value of 0.84, and
a negative predictive value of 0.59 (Figure 2).
Like procalcitonin, CRP was found to be highly correlated
with an infection ( p < 0.0001, Table 3). Even though the
sensitivity of the CRP was found to be much better (0.75)
than that of procalcitonin, its specificity was not as good
(0.66). ESR was also found to be significantly correlated with
an infection ( p = 0.025, Table 3). Nevertheless, its sensitivity
(0.51) and specificity (0.72) were found to be pretty low. The
ROC curves of all the markers are shown in Figure 2.
To try to enhance the sensitivity and the specificity of
these markers, we associated them. Adding ESR to procalci-
tonin did not help ( p = 0.91) to diagnose an infection in a
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Table 3 Baseline values of infectious markers in patients with an infection (group I) and those without an infection (group II)
Group I (N = 99) 95% CI Group II (N = 74) 95% CI p-Value
Fever >38 8C (%) 42 (42%) 10 (14%) <0.0001
Mean body temperature, 8C 38.7 37.8—40.1 36.9 36.7—37.1 <0.0001
Mean WBC count,  109/l (ranges) 15.4 14.4—16.4 13.6 12.7—14.5 0.007
Mean procalcitonin, ng/ml (ranges) 6.1 1.5—13.7 0.4 0.3—0.5 <0.0001
Mean C-reactive protein, mg/l 117 97—136 55 39—71 <0.0001
Mean sedimentation rate, mm/h 40 34—46 29 24—35 0.025
Figure 1 Receiver operating characteristic (ROC) curve of
leukocyte count for discrimination between presence and
absence of systemic infection.
Figure 2 Receiver operating characteristic (ROC) curves of: (A) gro
(C) C-reactive protein (CRP), and (D) erythrocyte sedimentation ra
systemic infection.patient hospitalized with leukocytosis. When CRP was ana-
lyzed with the gross levels of procalcitonin, the sensitivity
was close to that of the CRPalone. But when the cutoff model
of procalcitonin ( 0.5 ng/ml) was chosen, the addition of
CRP and ESR enhanced the sensitivity from 0.75 (sensitivity of
CRP alone) to 0.83, which was the best value found. Never-
theless this difference was not statistically significant
( p = 0.84) (Figure 3).
There were no differences with regard to all systemic
inflammatory markers between the different classes of infec-
tions, but some groups were too small to perform an analysis.
Discussion
The etiologic diagnosis of patients who present to an emer-
gency department with leukocytosis is complex and difficult.
Infections are a frequent cause of consultations in an emer-
gency department. Symptoms are sometimes vague and only
leukocytosis is present, but many other diseases may provokess level of procalcitonin, (B) cutoff of 0.5 ng/ml of procalcitonin,
te (ESR), for discrimination between presence and absence of
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Figure 3 Receiver operating characteristic (ROC) curve of
procalcitonin combined with C-reactive protein (CRP) and ery-
throcyte sedimentation rate (ESR).leukocytosis as well. The normal total WBC count in adults
varies from 4.4 to 11  109/l.12 Since the normal limits
include two standard deviations above the mean, 2.5% of
the normal population will have a total WBC count above
11  109/l. Because most microbiological test results are
not available within 24 h, a sensitive and specific marker of
systemic infection would be useful. Although the CRP level
is a very sensitive marker of inflammation, it lacks speci-
ficity and so has limited utility in these cases.13 In 1993,
Assicot et al.6 reported a correlation between a high serum
level of procalcitonin and sepsis. Other studies have
reported that procalcitonin level has a high sensitivity
and specificity for bacterial meningitis and for the systemic
inflammatory response syndrome diagnosed in an intensive
care unit.14,15 To date, there have been few procalcitonin
level evaluations in the emergency department.16 For this
reason, we conducted a prospective study involving
patients who presented to an emergency department with
leukocytosis.
Our study shows that procalcitonin has a relatively good
specificity (0.85) and positive predictive value (0.84), and a
poor negative predictive value (0.59) and sensitivity (0.57), if
a cutoff point of 0.5 ng/ml is chosen to predict an infection in
a patient who has attended the emergency room with leu-
kocytosis. Compared to Hausfater’s study in which all
patients who presented to the hospital were analyzed,16
whatever the leukocyte count, these values are very similar
(sensitivity 0.35, specificity 0.99, positive predictive value
0.96).
The value 10  109/l is more a historical value than a real
cutoff point and should not be used to predict an infection,
since around 50% of all patients with a leukocyte count higher
than 10  109/l were found not to be suffering from an
infection in our study. In Hausfater’s study, a leukocyte count
greater than 12  109/l was not independently associated
with the diagnosis of a systemic bacterial infection.16
Combining the markers brings no more information in
comparison to procalcitonin alone for the specificity and
positive predictive value, and the slightly enhanced sensi-
tivity due to CRP was not statistically significant. As sug-
gested by other studies,17 procalcitonin serum level is areliable marker of severity and prognosis, rather than a
sensitive marker of an infection.
These results, somehow disappointing, may have several
explanations. First, only patients with a leukocyte count
>10  109/l were included, whereas many patients with
severe systemic infections for which procalcitonin is con-
sidered as a very good marker17 have a low leukocyte count
and a massive left shift. Secondly, group I patients had
heterogeneous infectious diseases with various degrees of
gravity. Procalcitonin level determination has been reported
to be particularly useful for critically ill patients with severe
systemic inflammatory response, a population that is quite
different fromours.6,18 Another argument that could explain
our results concerns procalcitonin kinetics. Procalcitonin
levels are detected 3 h after synthesis induction, and the
half-life of procalcitonin is about 20—24 h.19,20 Most patients
admitted to the hospital due to infectious diseases do so
from the emergency department and then are transferred,
several hours later, to the medical department or the inten-
sive care unit. Procalcitonin levels in blood samples obtained
from patients in the emergency room reflect the earliest
biological inflammatory response and may be only slightly
elevated.
For many patients with leukocytosis presenting to the
hospital, whether they are suffering from an infection or
not, the diagnosis is quickly found without needing a pre-
dictive tool like procalcitonin. Nevertheless, this marker
can be useful for those for whom only leukocytosis is
present without other clinical signs. Future studies inte-
grating dosage of procalcitonin in a clinical algorithm
for patients without a clear-cut diagnosis appear to be
warranted.
Our study has several weaknesses. We did not look at
variables that were associated with false-negative procalci-
tonin test results as this was not the aim of the study. We also
did not analyze the influence of previous antibiotic treat-
ment on the inflammatory markers as this concerned only a
few patients. Finally, as we did not specifically look for viral
infections, some patients from group I could have been
suffering from a viral infection for which it is already known
that the main markers (procalcitonin and CRP) will not
significantly increase.21 Nevertheless, the main infections
diagnosed in our study (pyelonephritis, arthritis, osteomye-
litis, meningitis, cholangitis, and appendicitis) were of bac-
terial origin. Concerning patients with pneumonias, those
with viral infections only rarely require hospitalization,
which was a condition of inclusion in the study.Conclusions
In summary, our study shows that only about half of the
patients attending the emergency room with leukocytosis
are suffering from an infection. Taking a cutoff point of
0.5 ng/ml, procalcitonin has a weak negative predictive
value and sensitivity, but a relatively good specificity and
positive predictive value for detecting common non-viral
infectious diseases. Normal values do not exclude the pos-
sibility of an infectious process in the early stages. For this
reason, a lower threshold of 0.2 ng/ml has been proposed by
some authors.14 Adding other inflammatory markers like CRP
or ESR adds no further information.
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